Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab

There are an increasing number of treatments available for multiple sclerosis (MS). The early identification of optimal responders to individual treatments is important to achieve individualized therapy. With this aim, we performed a multicenter retrospective longitudinal study including 186 MS pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Dominguez-Mozo, Maria Inmaculada, Perez-Perez, Silvia, Villar, Luisa María, Oliver-Martos, Begoña, Villarrubia, Noelia, Matesanz, Fuencisla, Costa-Frossard, Lucienne, Pinto-Medel, María Jesús, García-Sánchez, María Isabel, Ortega-Madueño, Isabel, Lopez-Lozano, Lorena, Garcia-Martinez, Angel, Izquierdo, Guillermo, Fernández, Óscar, Álvarez-Cermeño, Jose Carlos, Arroyo, Rafael, Alvarez-Lafuente, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455689/
https://www.ncbi.nlm.nih.gov/pubmed/32859922
http://dx.doi.org/10.1038/s41598-020-71283-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455689/
https://www.ncbi.nlm.nih.gov/pubmed/32859922
http://dx.doi.org/10.1038/s41598-020-71283-5

Ejemplares similares